Shannon Maude MD

PubMed

• 3 citations
  Management Practices of CAR T-cell-Related Inflammatory Toxicities: A Survey of Pediatric CAR T-cell Providers.
  Kevin O McNerney, Caroline Diorio, Colleen Annesley, Rebecca A Gardner, Andrea K Graham
  Transplantation and Cellular Therapy. 2026-02-01
• The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.
  Liora Schultz, Kevin McNerney, Adam J Lamble, Friso G Calkoen, Andre Baruchel
  Nature Reviews. Clinical Oncology. 2026-01-23
• With BiTEs at the kiddie table, where do CARs come in for pediatric B-ALL?
  Amanda M Li, Shannon L Maude
  Hematology. American Society of Hematology. Education Program. 2025-12-05

Journal Articles

• Induction of Resistance to Chimeric Antigen Receptor T Cell Therapy by Transduction of a Single Leukemic B Cell  
  Vijay G Bhoj, David M Barrett, Carl H June, Stephan A Grupp, David E Ambrose, Saar I Gill, Marco Ruella, Bruce L Levine, Shannon L Maude, Nature

Abstracts/Posters

• Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy
  Shannon L. Maude, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Cytogenetic Characteristics and Outcomes of Patients Receiving CTL019 CAR T Cell Therapy
  Shannon L. Maude, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Trends in Inpatient and Intensive Care Resource Utilization after Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia from 2012-2019
  Shannon L. Maude, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Integrating CAR T-Cell Therapy Into the Treatment of Lymphoma, Myeloma, and Leukemia: Strategies for Maximizing Patient Outcomes 
  60th American Society of Hematology Annual Meeting - 11/30/2018